Full Year 2022 Biomerieux SA Earnings Call Transcript
Good day, and welcome to the bioMérieux Fiscal Year 2022 Conference Call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Mr. Franck Admant. Please go ahead.
©-
Thank you, Jennifer. Good day, everyone, and thank you for joining us to review bioMérieux's performance for 2022 and our objectives for 2023. Before leaving the floor to Alexandre Merieux, Chairman and CEO; Pierre Boulud, Chief Operating Officer, Clinical Operations; and Guillaume Bouhours, CFO, I will just make a very short introduction to provide you with a couple of information.
First of all, our press release was published this morning at 7:00 a.m. This press release can be found on our home page of our website. In addition, please note that the slides of this meeting will be also available on the home page and you will also be able to download them directly from the webcast. Promptly, after the meeting, the webcast and the call will be available in replay on our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |